New TAG data shows funding for TB research rose in 2017

A new brief from Treatment Action Group shows that global funding for TB research reached a new high of USD $767.8 million in 2017.

Read More →

Civil Society statement for the UN High-Level Meeting on TB

Joint statement on behalf of affected communities and civil society on the occasion of the first United Nations High-Level Meeting on the Fight to End Tuberculosis; Deadline for sign-on: 12:00 pm New York time, 25 September.

Read More →

Civil society and affected communities respond to WHO's Global TB Report 2018

Statement from civil society and affected communities in response to the World Health Organization (WHO)'s Global TB Report 2018.

Read More →

WHO calls for urgent action to end TB

WHO’s 2018 Global TB Report calls for an unprecedented mobilization of national and international commitments; First-ever United Nations High-Level Meeting on TB provides historic opportunity.

Read More →

Médecins Sans Frontières calls for affordable access to critical TB drug bedaquiline

Médecins Sans Frontières to Johnson & Johnson: We need affordable and sustainable supply of bedaquiline.

Read More →

Political Declaration on TB ready for approval at the UN High-Level Meeting

The Political Declaration was made public following the conclusion of a second silence procedure period.

Read More →

Communiqué and petition demanding more from the Political Declaration of the UN High-Level Meeting on TB

Join stakeholders under the umbrella of the Nairobi Strategy on TB and Human Rights in demanding more from the UN High-Level Meeting on TB by signing a petition.

Read More →

Urgent need to register essential medicines for the treatment and prevention of TB in South Africa

Advocates request that the South African Health Products Regulatory Authority expedite registration of essential medicines for the treatment and prevention of TB in South Africa.

Read More →

The TB CAB and TAG welcome WHO recommendation of injectable-free regimens for the treatment of RR/MDR-TB

The WHO, Ministries of Health and Finance, donors, implementers, technical assistance providers, civil society, and communities must work together to ensure rapid implementation.

Read More →

WHO announces landmark changes in MDR-TB treatment regimens

Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant TB (MDR-TB) are expected.

Read More →

Page 2 of 94 · Total posts: 10

←First 1 2 3 Last→